Pharmacology, Toxicology and Pharmaceutical Science
Haemophilia A
100%
Immunoglobulin
54%
Sepsis
50%
Blood Clotting Factor Concentrate
33%
Replacement Therapy
33%
Plasma Protein
30%
Clinical Trial Design
29%
Clinical Trial
28%
Immune Deficiency
26%
Blood Clotting Factor 8
26%
Infectious Agent
25%
Hetastarch
21%
Pharmacokinetics
21%
Liver Cirrhosis
19%
Alpha 1 Antitrypsin Deficiency
19%
Bleeding Disorder
17%
Blood Clotting Factor
17%
Prevalence
13%
2 Decanoylamino 3 Morpholino 1 Phenyl 1 Propanol
13%
Bacterial Peritonitis
13%
Rare Disease
13%
Neuropathy
13%
Antioxidant
13%
Humoral Immune Deficiency
13%
PEGylation
13%
Convalescence
13%
Human Albumin
13%
Immunotherapy
13%
Bleeding
13%
Diseases
11%
Salicylate Sodium
10%
Infection
10%
Good Manufacturing Practice
10%
Essential Medicines
10%
X Linked Agammaglobulinemia
9%
Common Variable Immunodeficiency
9%
Liver Disease
8%
Randomized Controlled Trial
8%
Bloodborne Bacterium
8%
Adverse Event
8%
Biological Activity
6%
Plasma Substitute
6%
Anti-Inflammatory Drug
6%
Antiinflammatory Activity
6%
Clinical Study
6%
Small Clinical Trial
6%
Neutralizing Antibody
6%
Disease Course
6%
Burn
6%
Immunogenicity
6%
Medicine and Dentistry
Haemophilia A
60%
Health Care Cost
39%
Blood Transfusion
32%
Clinical Trial Design
30%
Blood Clotting Factor 8
26%
Health Care
25%
Clinical Trial
23%
Blood Donor
23%
Cost-Effectiveness Analysis
22%
Sepsis
21%
Alpha 1-Antitrypsin Deficiency
19%
Pathogen
19%
Hydroxyethyl Starch
16%
Immunoglobulin
15%
Renal Replacement Therapy
14%
Immune Deficiency
13%
Rare Disease
13%
Transfusion Medicine
13%
Network Meta-Analysis
13%
Relative Survival
13%
Neuropathy
13%
2 Decanoylamino 3 Morpholino 1 Phenyl 1 Propanol
13%
Stereotypy
13%
Blood Proteins
13%
Plasmapheresis
13%
Immunotherapy
13%
Serum Total Protein
13%
Blood Safety
13%
Evolution
13%
Blood Clotting Factor Concentrate
10%
Hemophilia Therapy
10%
Essential Medicines
10%
Prevalence
9%
Client
8%
Medicine
8%
Diseases
7%
Blood Clotting Factor
6%
Blood Stasis
6%
Thrombosis
6%
Patient Recruitment
6%
Adverse Event
6%
Bleeding Disorder
6%
Thermal Burn
6%
Bleeding
6%
Copurification
6%
Chronic Disorder
6%
Biological Activity
6%
Disease
6%
Meta-Analysis
6%
Health System
5%
Nursing and Health Professions
Haemophilia A
32%
Fractionation
32%
Blood Transfusion
30%
Quality Adjusted Life Year
21%
Sepsis
19%
Blood Bank
17%
Cost Utility Analysis
13%
2 Decanoylamino 3 Morpholino 1 Phenyl 1 Propanol
13%
Blood Clotting Factor 8
13%
Bleeding Disorder
13%
Blood Clotting Factor
13%
Bacterial Peritonitis
13%
Hetastarch
13%
Network Meta-Analysis
13%
Plasma Protein
13%
Plasmapheresis
13%
Nutrition Policy
13%
Blood Donor
10%
Incremental Cost-Effectiveness Ratio
8%
Reimbursement
8%
Renal Replacement Therapy
8%
Client
8%
Medline
8%
Blood Safety
8%
Cost Effectiveness Analysis
8%
Thermal Burn
6%
Immune Deficiency
6%
Bleeding
6%
Health Care Need
6%
Haemophilia B
6%
Alpha 1 Antitrypsin Deficiency
6%